全部分类
  • SIRT2-IN-9
SIRT2-IN-9的可视化放大

SIRT2-IN-9

SIRT2-IN-9 (compound 12) 是 SRIT2 的选择性抑制剂,IC50 值为 1.3 μM。SIRT2-IN-9 抑制 MCF-7 乳腺癌细胞的增殖活性。SIRT2-IN-9 可用于癌症的研究。

此产品仅用于科学研究,我们不为任何个人用途提供产品和服务

SIRT2-IN-9的二维码
  • 库存: 现货
可选规格
  • 包装
    价格
    促销价
    数量
  • 10mg
    ¥1412.00
    1130.00
    - +
  • 25mg
    ¥2937.00
    2350.00
    - +
  • 50mg
    ¥4700.00
    3760.00
    - +
  • 100mg
    ¥7562.00
    6050.00
    - +
已选 0 0
金额: ¥0.00
首页 收藏
  • 货号: ajcf13782
  • CAS: 522650-91-5
  • 别名:
  • 分子式: C21H22N6OS2
  • 分子量: 438.57
  • 纯度: >98%
  • 溶解度: DMSO : 4.46 mg/mL (10.17 mM; ultrasonic and warming and heat to 70°C)
  • 储存: 4°C, protect from light
  • 库存: 现货

Background

SIRT2-IN-9 (compound 12) is a selective inhibitor of SRIT2 with an IC50 value of 1.3 μM. SIRT2-IN-9 inhibits proliferative activity of MCF-7 breast cancer cells. SIRT2-IN-9 can be used for the research of cancer[1].


SIRT2-IN-9 (1-100 μM; 15 min) dose-dependently inhibits SRIT2 with an IC50 value of 1.3 μM, and inhibits SRIT1 and SRIT3 with IC50s >300 μM[1].
SIRT2-IN-9 (0-50 μM; 72 h) affects cell viability of MCF-7 cells[1].
SIRT2-IN-9 (0-50 μM; 6 h) affects acetylation of α-tubulin protein[1].

Cell Proliferation Assay[1]

Cell Line: MCF-7 breast cancer cell line
Concentration: 0-50 μM
Incubation Time: 72 hours
Result: Dose-dependently inhibited cell proliferation of MCF-7 breast cancer cells.

Western Blot Analysis[1]

Cell Line: MCF-7 breast cancer cell line
Concentration: 6.25, 12.5, 25 and 50 μM
Incubation Time: 6 hours
Result: Dose-dependently increased acetylation of α-tubulin protein.

没有评价数据

温馨提示 ×
商品已成功加入购物车!
购物车共 0 件商品
去购物车结算